Light therapy during brain surgery shows promise for deadliest brain cancer

NCT ID NCT05736406

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times

Summary

This study tests a new treatment called photodynamic therapy (PDT) for people with a severe brain cancer called glioblastoma. During surgery to remove the tumor, a special drug and light are used to kill remaining cancer cells. The goal is to find the safest light dose and see if this approach can help control the disease when added to standard chemotherapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU De Lille, Hôpital Roger Salengro

    RECRUITING

    Lille, 59037, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • UPMC Hillman Cancer center

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.